Showing results (71-80 of 143) with videos related to
Sort By:
Pageof 15
British Journal of Clinical Pharmacology|July 25, 2022
Use of medication data alone to identify diagnoses and related contraindications: Application of algorithms to close a common documentation gapWahram Andrikyan, Melanie I Then, Karl-Günter Gaßmann, et al.Methods of Information in Medicine|April 29, 2017
Data Requirements for the Correct Identification of Medication Errors and Adverse Drug Events in Patients Presenting at an Emergency DepartmentBettina Plank-Kiegele, Thomas Bürkle, Fabian Müller, et al.Journal of Clinical Pharmacology|February 27, 2007
Pharmacokinetics of oral doses of telmisartan and nisoldipine, given alone and in combination, in patients with essential hypertensionMilica Bajcetic, Ralf A Benndorf, Daniel Appel, et al.Metabolism: Clinical and Experimental|August 22, 2006
Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertensionRalf A Benndorf, Tanja Rudolph, Daniel Appel, et al.BMJ Quality & Safety|October 1, 2024
Artificial intelligence-powered chatbots in search engines: a cross-sectional study on the quality and risks of drug information for patientsWahram Andrikyan, Sophie Marie Sametinger, Frithjof Kosfeld, et al.Journal of Nephrology|February 11, 2012
Measuring asymmetric dimethylarginine (ADMA) in CKD: a comparison between enzyme-linked immunosorbent assay and liquid chromatography-electrospray tandem mass spectrometryPaola Pecchini, Fabio Malberti, Maren Mieth, et al.Plos One|September 12, 2013
Homoarginine and mortality in pre-dialysis chronic kidney disease (CKD) patientsPietro Ravani, Renke Maas, Fabio Malberti, et al.Journal of Hypertension|September 9, 2005
The GLU298ASP variant of nitric oxide synthase interacts with asymmetric dimethyl arginine in determining cardiovascular mortality in patients with end-stage renal diseaseAlessandra Testa, Belinda Spoto, Giovanni Tripepi, et al.Dementia and Geriatric Cognitive Disorders|July 12, 2008
Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's diseaseSönke Arlt, Friedrich Schulze, Martin Eichenlaub, et al.Atherosclerosis|July 11, 2006
Asymmetrical dimethylarginine (ADMA) and coronary endothelial function in patients with coronary artery disease and mild hypercholesterolemiaRenke Maas, Kurt Quitzau, Edzard Schwedhelm, et al.Pageof 15